chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case reported by a nurse, describes the occurrence of decreased body temperature (cold temperature), cough, pain (body aches) and chills in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 09L20A) for COVID-19 immunization. Medical history not provided. On Feb 3, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Feb 3, 2021, patient experienced decreased body temperature (cold temperature), cough, pain (body aches) and chills. February 2021, decreased body temperature (cold temperature), cough, pain (body aches) and chills resolved. The reporter did not provide any causality assessments, concomitant product use or treatment information. Sender's comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient presented to the Emergency Room with progressive left facial swelling over 1 week - was found to have a mandibular abscess. He was admitted for intravenous antibiotic treatment.  Patient did improve symptomatically with respect to swelling and pain.  His CRP improved slightly.  He was treated with intravenous Clindamycin throughout hospitalization and did discuss with oral surgeon on-call.  Per oral surgery, the patient will be able to be discharged today and will have an appointment tomorrow in the oral surgery clinic for definitive treatment debridement of abscess and he will continue on his oral Clindamycin on discharge. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Patient develop swelling in right leg. Doppler was preformed and DVT was discovered. Patient was placed on Eliquis.
Patient didn't experience pain on injection, but after 3 days had extreme swelling and redness from deltoid muscle down to elbow. Observed today and there is still quite a bit of swelling, but none at injection site.
This infant had swelling, pain, redness with fluctuance and warmth at the injection site on the right upper thigh with splotching..
pt recv vax; approx 4 days p/ vax, exp T 106 for 1 wk; also exp weight loss, loss of appetite; change in personality, cranky,crying all the time, limping, falling,losing balance when walking;
Patient came into pharmacy with a Rx for ZOSTAVAX at noon on 09/29/11. RPh picked up a vaccine from freezer and prepared and gave vaccine. Afterwards she went to do paperwork and the label to be peeled for VAR was a varicella. She promptly told staff about incident..
Pt received vaccine at outside clinic (mobile clinic) on 2/6/22.  This is her 3rd Moderna vaccine.  The night of 2/6 she developed pain/redness in left deltoid.  Pain improved but redness & swelling has worsened.  Lesion size: 7cm x 5.5 cm.  Hot, warm and tender.  Given Keflex 500mg TID x 5 days for cellulitis reaction.
Moderate headache, joint stiffness, muscle aches and skin sensitivity began 8 hours after injection and lasted 36 hours.
shortness of breath; sore throat; cough; This is a spontaneous report from a non contactable consumer(patient) reported for herself. A 23-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 20Apr2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. Historical vaccine included: first dose of COVID-19 VACCINE as dose 1, single for COVID-19 immunization. Patient received the 2nd dose of Pfizer vaccine on Tuesday the 20th, started getting sore throat day of vaccine, next day started with shortness of breath and cough. Patient wanted to know how long these were going to last? at what point should patient be concerned? Patient asked at what point should patient get medical attention, patient was having trouble breathing. What are the risks, Side effects after second shot may be more intense than the ones experienced after first shot. These side effects were normal signs that body was building protection and should go away within a few days. It was mentioned that, doctor/health care provider in the best position to assess and advise as doctor/health care provider was most familiar with your medical condition, clinical history, how treatment has been conducted and any relevant information to your specific case. Patient went to ER yesterday, they told me to stay hydrated. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative. The outcome of the events were unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Chest pain Abdominal pain Fever, severe chills, diaphoresis Seizure like activity for two night
2 days(approximately 48 hours) after dose.  Severe headache sore throat, aches in legs, arms, shoulders, swollen lymph nodes, tiredness
This case was reported by a physician via sales rep and described the occurrence of migraine type headaches in a 65-year-old female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced migraine type headaches, feeling unwell and activities of daily living impaired. On an unknown date, the outcome of the migraine type headaches, feeling unwell and activities of daily living impaired were recovered/resolved. It was unknown if the reporter considered the migraine type headaches, feeling unwell and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX dose at an unknown pharmacy. The patient experienced migraine like headache that lasted for 3 to 4 days. This reportedly affected daily activity to point could not care out normal functions for at least 3 days. The patient reported the headache as debilitating as general feeling of being sick.
"1:26pm- 15y/o male reported he was feeling dizziness and was brought to the observation room.  Pt vomited a small amount.   1:28pm - Pt was transferred to bed. VSS and WNL.  BP 111/71, HR 83, RR 24. Pt had no prior hx of dizziness, vomiting after vaccination.  Pt was checked by MD.  No Resp distress, allergic rxn to vaccination was observed.  Pt drank 16oz water and reported feeling better. 1:39pm - Second vitals 111/70, HR 84, RR 20. Pt walked around the room w/ PA and was communicating w/ father & RN. 1:41pm Pt stable and released from the vaccination site with father."
EMPLOYEE OBSERVED FOR 30 MINUTES, NO REACTION, CAME BACK NOT FEELING WELL EMPLOYEE DID NOT EAT TODAY, MAIN C/O IS BLURRED VISION. EMPLOYEE RECOMMENDED TO GO TO ER FOR EVALUATION.
Product temperature excursion issue; Patient administered moderna covid vaccine while temperature excursion was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) in a 75-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .25 milligram. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information were provided.  Patient did not report any adverse events.   This case was linked to MOD-2022-501575 (Patient Link).
Patient stated she had cough, congestion, and  "head pain under the scalp" following the injection.  She also stated she had some soreness at the injection site following the injection.  She was advised to follow up with a physician.
injection site was red and had a rash achy chills extreme joint pain on left side, hip, knee and ankle cough
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On 07-APR-2015, the patient was vaccinated with a dose of improperly stored PEDVAXHIB (lot number reported as K001124, Expiry Date: 16-OCT-2016) (dose and route were not reported). No adverse experiences were reported. This is one of several reprots received from the same reporter. Additional information has been requested.
VOMITING; NAUSEA; FATIGUE; SURGE OF ENERGY; This spontaneous report received from a patient concerned a 68 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included stage 4 prostate cancer, and sulfonamide allergy. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 14-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 14-MAY-2021, the subject experienced surge of energy. On 16-MAY-2021, the subject experienced vomiting. On 16-MAY-2021, the subject experienced nausea. On 16-MAY-2021, the subject experienced fatigue. The action taken with covid-19 vaccine  was not applicable. The patient recovered from surge of energy on 16-MAY-2021, and had not recovered from nausea, vomiting, and fatigue. This report was non-serious.
Approximantly 2 weeks after receiving the first shot my right arm  (where I got the injection)started to swell, get extremely red, and itch.  This got worse over the course of a few days where the swelling covered my complete upper arm.  This went away after 3 days.
Headache, whole right side of my body hurts, rash from elbow up towards shoulder(itches)
First dose of Shingrix on 9/11/2019 / Second dose of Shingrix not administered yet; Difficulty breathing; Asthma exacerbation; Redness on her left arm around injection site; Affected area was described as itchy; affected area was described was raised; This case was reported by a pharmacist via call center representative and described the occurrence of difficulty breathing in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included seasonal allergy, asthma and rhinorrhoea (which typically occurs every fall). Concomitant products included antihistamine (Antihistamines).   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. On 12th September 2019, 1 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced difficulty breathing, asthma aggravated, injection site erythema, injection site itching and injection site swelling. On an unknown date, the patient experienced incomplete course of vaccination. The patient was treated with prednisone. On 15th September 2019, the outcome of the difficulty breathing and asthma aggravated were recovered/resolved. On an unknown date, the outcome of the injection site erythema was recovered/resolved and the outcome of the injection site itching, injection site swelling and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the difficulty breathing, asthma aggravated, injection site erythema, injection site itching and injection site swelling to be related to Shingrix.  Additional details were reported as follows: The patient said that the day before Shingrix vaccination had a runny nose which typically occurs every fall due to seasonal allergies from tree. At the time of vaccination the patient has being on anithistamines due to this. The patient reported medical history significant for acute asthma and bronchiole airways that overreacted. The patient received 1st dose of Shingrix and next day after vaccination, had difficulty breathing and an asthma exacerbation that lasted approximately 3 to 4 days. The patient went to an urgent care to undergo treatment and was prescribed Prednisone 60 milligram for 10 days. The reporter also reported redness on her left arm around the injection site that was approximately the size of a softball. The affected area was described as itchy and raise approximately 1/16th to 1/8th of an inch. The redness reportedly lasted over one week. The patient did not received 2nd dose of Shingrix till the time of report, which led to incomplete course of vaccination. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020209434:same reporter US-GLAXOSMITHKLINE-US2020209436:same reporter US-GLAXOSMITHKLINE-US2020209432:same reporter
pt recvd vax;felt flushed & funny;blisters rash on neck & ears;no swelling or rash;around mouth or tongue;BP 140/92, P=104;dph given;having trouble w/ asthma;mom cont to have f/u w/ PMD;
may have blood clots; since she took the first COVID vaccine, she did have some symptoms. Her face flushed, like she had a temperature and experienced fatigue; since she took the first COVID vaccine, she did have some symptoms. Her face flushed, like she had a temperature and experienced fatigue; since she took the first COVID vaccine, she did have some symptoms. Her face flushed, like she had a temperature and experienced fatigue; This is a spontaneous report from a contactable consumer received from a non-Pfizer sponsored program,, received from a contactable consumer, based on information received by Pfizer. This case is split for a 80 year old patient taking COVID vaccine and experienced face flushed, fatigue.  This 80-year-old female patient received first dose of (PFIZER BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiration date: unknown), dose 1 via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunization. Medical history included high frequency ablation (vein), breast cancer from 2015 to an unknown date (34 radiation treatment to left breast and no recurrence of the cancer), radiotherapy (breast cancer), atrial fibrillation from Jan2016 to an unknown date, surgery (she had 6 veins removed from her legs). Concomitant medication(s) included apixaban (ELIQUIS) taken for cerebrovascular accident prophylaxis (batch no. 1745824) (oral, 5 milligram, twice a day) in 2017 or 2018, losartan taken for blood pressure (50 mg once daily), paracetamol (TYLENOL) taken for pain (as needed (but not every day)), vitamin b nos, ascorbic acid, zinc, colecalciferol and cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]). The patient experienced since she took the first COVID vaccine, she did have some symptoms, her face flushed, like she had a temperature and experienced fatigue, and may have blood clots. The patient reported that she may have blood clots but was unsure because she did not underwent any tests to confirm. The patient was due for her second COVID-19 vaccination. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Awoke knowing I was not feeling well. Had severe headache, nausea, body aches, chills, fever up to 101.6-normal temperature is 97.2. Symptoms lasted all day. Started feeling better mid-afternoon and fever broke. Sore muscle at injection site. Was back to normal after evening dinner and next day.
Chills on-and-off for close to 48 hours, body aches pretty consistently for 48 hours, fever that peaked at 101.2F within 24 hours and fluctuated between normal and 100.5F for 48 hours, nausea and light sensitivity at height of fever, fatigue throughout. For treatment, drank plenty of water, ate Club crackers for nausea, and took Advil cold& flu (ibuprofen, phenylephrine hcl, chlorpheniramine maleate) according to dosing instructions.
two days after the vaccine she developed swelling in the lower ext which progressed to palpitations and SOB. She was diagnosed with DVT/PE and cor pulmonale upon admission on 9/14/21. She was started on anticoagulation and IVC filter placed.  She has had subsequent thrombophilia work up with a hematologist which was unrevealing.
RECIEVED VACCINE ON THURSDAY, ON SUNDAY PATIENT REPORTS THAT SHE STARTED HAVING SHOOTING PAIN FROM LEFT THIGHT DOWN TO FEET, ON SCALE OF 1-10 PATIENT RATES PAIN AT 8.  SHE REPORTS THAT PAIN IS ABOUT THE SAME TODAY
Patient with cubital tunnel symptoms since one week after the vaccine and still present constantly for 4 weeks.
On 12/13/09, I had an episode of pronounced dizziness lasting approx. 1 hour.  Since then, I have had similar episodes lasting 1-2 hours on 12/16/09, 12/28/09, 12/31/09, and 1/4/10, as well as frequent momentary dizziness or imbalance.  Treatment for these symptoms has been to increase the dosage on my migraine preventive medication for the last 1 1/2 weeks.
This is a spontaneous report from a contactable consumer and from a contactable health care professional (HCP). A 51-year-old female patient of an unspecified ethnicity received a single dose of PREVNAR13, via an unspecified route of administration, on 04NOV2014. The patient's medical history included ulcerative colitis and ongoing chronic bronchitis since an unknown date. Concomitant medications were none. On 05NOV2014, the patient experienced red circular spots on arm, also described as red circles the size of a quarter around the injection spot. The patient mentioned that she had called her pharmacist and they said that there was not need to worry and that the spots would have gone away. On 05NOV2014 she experienced stiffness in her body/stiffness in both her arms, all the joints in her body were severely in pain all of the joints in her body were brutally painful, all the muscles specially the arm muscles were aching/muscle pain. ON an unknown date in NOV2014, a week after vaccination, she had bad headache/non-stop headaches, head to toe tingly feeling/weird sensations, eye pain, heavy  feeling in lifting of limbs. Within two weeks, on 20NOV2014, she was in her doctor's office. The doctor did blood work which sowed the ANA was a little bit up, all other numbers ere fine. The patient did not receive treatment for the rash macular. She received anti-inflammatory treatment for the stiffness, joint pain, muscle pain, headache, paraesthesia, eye pain, heaviness in limbs and she was sent to a Rheumatologist for all adverse events. The patient reported that all of the symptoms were starting to dissipate, however, the clinical outcome for the events of stiffness in body/stiffness in both her arms, all the joints in her body were severely in pain/all of the joints in her body were brutally painful, all of the muscles specially the arm muscles were aching/muscle pain, a head to toe tingly feeling/weird sensations, heavy feeling in lifting her limbs was not recovered. The clinical outcome for the event Eye pain, had bad headache/non-stop headaches, of red circular spots on arm/red circles the size of a quarter around the injection spot was recovered on an unknown date in NOV2014. The patient did not provide any information to the reporting HCP regarding the previously reported adverse events with the use of the product. Follow-up (12DEC2014): New information reported from a contactable consumer includes: added relevant medical history, added relevant lab data, and added events of a head to toe tingly feeling/weird sensations, eye pain, heavy feeling in lifting her limbs. Follow-up (05JAN2014): Additional information reported from the same contactable consumer includes date of birth provided, outcome and treatment received fro the events. Follow-up (09FEB2015): New information from a contactable health care professional incldues: was not aware of the reported adverse events.  Follow-up attempts completed. No further information expected.
PATIENT FELT FAINT AFTER THE INJECTION, THEN USED ICE PACK AND WATER TO HELP COOL DOWN
Pt received PNEUMOVAX 23 on his right arm on 2/23/17. He is complaining of tingling pain and not being able to lift the arm. His MD prescribed KEFLEX, Naproxen, a TYLENOL w/codeine today. I will follow up with him in 3 days.
Treatment: Ice alternating with heat, Motrin/Tylenol PRN; 10.5cm diameter erythematous area of R deltoid warm to touch and tender to palpation.  Central firm area of 5 cm diameter.
Pt has redness, swelling and felt hot to touch on the site that injection was given.
The pt developed local reaction. The area was reddened and firm to touch. Area was first noticed on 1/5/02. It is already resolving (less red and firm) when seen in office for evaluation on 1/8/02.
Significant ringing in ears that wont go away. Headache, whole body ache, nausea, vomiting, fever, arm pain, stiffness, light sensitivity, headache.
p/vax pt had MS exacerbation; h/a; tingling & electrical sensation across face; eye pain & blurry vision progressing to full blown optic neuritis; saw MD who placed pt on IV solu-Medrol; advised not to have anymore immun
Suicide attempt. Overdose #45 Ibuprofen 800mg. Denies depression - Neg PMH depression.
First day entire body hurt to touch.  Second and third day whole body ache.  Fourth day extreme fatigue with any exertion, I could not walk up 7 stairs without my body feeling like it was full of lead.  Fifth day fatigue with exertion but not as bad
15 month 3 day old male presents with c/o Concerns and questions for 1 day redness right thigh at the area of injection site for DTaP; started today at 12 PM; area getting a little bigger since then, in the past 4 hours; also rash on the back since this afternoon. C/O rash for 1 day non-pruriginous on right thigh and back as above.
headache; migraine; feeling cold; not feeling good; coughing; This is a spontaneous report from a Pfizer-sponsored Program via contactable consumer (patient) reported for herself that.   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. The patient experienced headache, migraine, feeling cold, not feeling good and coughing on an unspecified date. Patient received treatment in response to the events. It was reported that, Caller had headache and was tried to look for her card. Was supposed to get her second dose on the 14Apr2021 but couldn't find it. caller now had migraine from looking for it. Caller would like to change the appointment from 14Apr2021 to 20Apr2021 or 21Apr2021. Was feeling cold and was not feeling good and coughing and 10 days later still felt the same way. Tried taking Zyr-tec and that wasn't working. Transferred to Pfizer DSU but due to long hold times transferred to queue from CoVax US Support CEP 159558. The outcome of the events was not recovered.  Medical Information: Were any unaddressed medical questions referred or forwarded to Medical Information? No.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.